Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-125338
Filing Date
2024-11-12
Accepted
2024-11-12 16:05:32
Documents
66
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lgvn-20240930.htm   iXBRL 10-Q 1988916
2 EX-31.1 lgvn-ex31_1.htm EX-31.1 13876
3 EX-31.2 lgvn-ex31_2.htm EX-31.2 13941
4 EX-32.1 lgvn-ex32_1.htm EX-32.1 11843
5 GRAPHIC img237792832_0.jpg GRAPHIC 444907
  Complete submission text file 0000950170-24-125338.txt   8759576

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lgvn-20240930.xsd EX-101.SCH 1104437
69 EXTRACTED XBRL INSTANCE DOCUMENT lgvn-20240930_htm.xml XML 1198871
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40060 | Film No.: 241447969
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)